Polynucleotides Under Eyes Treatments in London

Results from a course of polynucleotide treatment may last between nine and eighteen months, though this varies between individuals. The quality and duration of results depend on factors including the number of sessions completed, the severity of the original concerns, skin condition, lifestyle, and how well the tissue responded to treatment. Maintenance treatment is generally recommended once or twice a year to sustain the improvements in skin quality, hydration, and the reduction in dark circles and fine lines achieved through the initial course.

Polynucleotides are generally considered a well-tolerated treatment when administered by a qualified and experienced practitioner. Adverse events do occur and can include temporary swelling, bruising, redness, or tenderness at injection sites. The periorbital area requires particular technical care, given the proximity to the eye and the thinness of the tissue. A thorough consultation, complete medical history review, and appropriate patient selection are essential elements of a responsible treatment pathway.

Most patients begin with a course of two to three sessions, typically spaced three to four weeks apart. The number of sessions recommended depends on the severity of the concerns being treated, baseline skin quality, individual tissue response, and whether polynucleotides are being used alone or alongside complementary treatments such as tear trough filler. A personalised treatment plan tailored to your anatomy and specific concerns will be outlined during consultation.

Discomfort during polynucleotide treatment beneath the eyes is generally mild and manageable. A topical anaesthetic is applied beforehand to reduce sensation at the injection sites. The periorbital region is more sensitive than many other facial areas, and some patients experience brief stinging or pressure during injection. Most find the procedure well within tolerance. Any discomfort typically resolves quickly, and there is no significant recovery time required following treatment.

Tear trough filler, typically hyaluronic acid-based, adds structural volume to the hollow beneath the eye and may provide immediate visual correction of shadow and indentation. Polynucleotide treatment works differently — it is used with the aim of supporting skin quality, hydration, and tone over time without volumising the area. The two approaches address different aspects of under-eye ageing and, in some cases, are used together as part of a comprehensive and individually planned treatment programme.

Unlike dermal fillers, which produce visible changes immediately after injection, polynucleotide treatment works progressively. Initial improvements in skin hydration may be noticeable within two to three weeks. More meaningful changes in skin texture, the appearance of fine lines, and the visibility of dark circles may continue to develop over six to twelve weeks as tissue response progresses. The gradual nature of the results is one reason this treatment is well-suited to the under-eye area, where subtle, natural-looking improvement is usually the primary goal.

Suitable candidates are typically adults experiencing reduced skin quality, fine lines, dark circles, or mild crepiness beneath the eyes that are primarily related to skin condition rather than significant volume loss. Those with very deep structural hollowing may benefit more from tear trough filler, either alone or combined with polynucleotides. Suitability is always confirmed following a full clinical consultation, assessment of individual anatomy, medical history review, and a clear discussion of treatment goals and expected outcomes.

Downtime following polynucleotide injections beneath the eyes is typically minimal. Mild redness, swelling, or bruising at the injection sites may occur and usually resolves within one to three days. The under-eye area can be more prone to bruising than other facial regions due to the fragility of the local vasculature. Most patients resume normal daily activities within 24 to 48 hours. Specific post-treatment instructions will be provided, including guidance on skincare, sun exposure, and physical activity in the days following each session.

Polynucleotide treatments under the eyes are generally considered safe, but they can cause temporary side effects such as swelling, redness, bruising, and mild tenderness at the injection site. In rare cases, patients may experience allergic reactions, infection, uneven results, or small lumps under the skin if the product is injected incorrectly or aftercare instructions are not followed.